A Crossover Design for Comparative Efficacy-Reference-Cited by-同舟云学术

A Crossover Design for Comparative Efficacy

Published:2016-04 Issue:4 Volume:123 Page:841-849
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Wiley Henry E.,Thompson Darby J.S.,Bailey Clare,Chew Emily Y.,Cukras Catherine A.,Jaffe Glenn J.,Lee Richard W.J.,Loken Erin K.,Meyerle Catherine B.,Wong Wai,Ferris Frederick L.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference40 articles.

1. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema;Diabetic Retinopathy Clinical Research Network;N Engl J Med,2015

2. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema;Diabetic Retinopathy Clinical Research Network;Ophthalmology,2010

3. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema;Mitchell;Ophthalmology,2011

4. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE;Nguyen;Ophthalmology,2012

5. Intravitreal aflibercept for diabetic macular edema;Korobelnik;Ophthalmology,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-06-27

2. Reliably Estimating the Impact of a New Control Strategy in a Building;2023

3. Anti-vascular endothelial growth factor for diabetic macular edema: a Bayesian network analysis;2022-06-14

4. Monoclonal antibodies in diabetic retinopathy;Expert Review of Clinical Immunology;2022-02-01

5. Impact of Injection Protocol Selection by Retina Specialists on Clinical Outcomes in Patients with Diabetic Macular Edema;Life;2021-12-31